Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

N Engl J Med. 2007 Sep 27;357(13):1281-92.

2.

Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.

Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.

Pediatrics. 2010 Oct;126(4):656-64. doi: 10.1542/peds.2010-0309. Epub 2010 Sep 13.

PMID:
20837594
3.

Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.

Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chiarotti F, Salmaso S.

Pediatrics. 2009 Feb;123(2):475-82. doi: 10.1542/peds.2008-0795.

PMID:
19171612
4.
5.

Early thimerosal exposure and neuropsychological outcomes.

Bernard S.

N Engl J Med. 2008 Jan 3;358(1):93; author reply 94. doi: 10.1056/NEJMc072980. No abstract available.

6.

Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.

Young HA, Geier DA, Geier MR.

J Neurol Sci. 2008 Aug 15;271(1-2):110-8. doi: 10.1016/j.jns.2008.04.002. Epub 2008 May 15.

PMID:
18482737
7.

Early thimerosal exposure and neuropsychological outcomes.

Rooney JP.

N Engl J Med. 2008 Jan 3;358(1):93-4; author reply 94. No abstract available.

PMID:
18175387
8.

Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.

Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT; Vaccine Safety Datalink Team.

Pediatrics. 2003 Nov;112(5):1039-48. Erratum in: Pediatrics. 2004 Jan;113(1):184.

PMID:
14595043
9.

Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.

Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.

Acta Paediatr. 2007 Jun;96(6):864-8. Epub 2007 Apr 27.

PMID:
17465985
10.

Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later.

Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW.

J Pediatr Psychol. 2012 Jan-Feb;37(1):106-18. doi: 10.1093/jpepsy/jsr048. Epub 2011 Jul 23.

PMID:
21785120
11.

Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.

Mrozek-Budzyn D, Majewska R, Kieltyka A, Augustyniak M.

Neurotoxicol Teratol. 2012 Nov-Dec;34(6):592-7. doi: 10.1016/j.ntt.2012.10.001. Epub 2012 Oct 13.

PMID:
23069197
12.

Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.

Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.

Pediatrics. 2004 Sep;114(3):584-91.

PMID:
15342825
13.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
14.

Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.

Marques RC, Dórea JG, Bernardi JV.

Acta Paediatr. 2010 Jun;99(6):934-9. doi: 10.1111/j.1651-2227.2009.01641.x. Epub 2009 Dec 9.

PMID:
20003103
15.

Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.

Marques RC, Dórea JG, Fonseca MF, Bastos WR, Malm O.

Eur J Pediatr. 2007 Sep;166(9):935-41. Epub 2007 Jan 20.

PMID:
17237965
16.

Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.

Parker SK, Schwartz B, Todd J, Pickering LK.

Pediatrics. 2004 Sep;114(3):793-804. Review. Erratum in: Pediatrics. 2005 Jan;115(1):200.

PMID:
15342856
17.

Continuing increases in autism reported to California's developmental services system: mercury in retrograde.

Schechter R, Grether JK.

Arch Gen Psychiatry. 2008 Jan;65(1):19-24. doi: 10.1001/archgenpsychiatry.2007.1.

PMID:
18180424
18.

Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.

Geier DA, Mumper E, Gladfelter B, Coleman L, Geier MR.

Neuro Endocrinol Lett. 2008 Apr;29(2):272-80.

PMID:
18404135
19.

[Lack of association between thimerosal-containing vaccines and autism].

Mrozek-Budzyn D, Majewska R, Kiełtyka A, Augustyniak M.

Przegl Epidemiol. 2011;65(3):491-5. Polish.

PMID:
22184954
20.

Regression of language and non-language skills in pervasive developmental disorders.

Meilleur AA, Fombonne E.

J Intellect Disabil Res. 2009 Feb;53(2):115-24. doi: 10.1111/j.1365-2788.2008.01134.x. Epub 2008 Nov 27.

PMID:
19054269

Supplemental Content

Support Center